Ying Tang

Ying Tang practices at Chickasaw Nation Medical Center in Ada, Oklahoma, part of The Chickasaw Nation.

Ying Tang's NPI, 1619537784, was assigned on June 19, 2019. Ying Tang holds Indiana license 02006864A.

Ying Tang's primary practice is Chickasaw Nation Medical Center, at 1921 Stonecipher Blvd, Ada, OK 74820 in Pontotoc County. The practice phone is (580) 436-3980.

Ying Tang's primary practice is Chickasaw Nation Medical Center in Ada, Oklahoma, part of The Chickasaw Nation. The medical group on file is Chickasaw Nation Medical Center. Dmand AI also links Ying Tang to 1 more medical group, named with a free account. Ying Tang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Ying Tang practices. Vendor and product names are available with a free account.

Hospitalist is Ying Tang's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Ying Tang's licenses on file in 2 states: Indiana and Oklahoma.

CMS data shows 173 Medicare services from Ying Tang across 4 procedure codes in 2024, for 116 Medicare patients. Medicare paid $14,817 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Ying Tang in 2024. The largest group is 75 to 84, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ying Tang's median patient age at 72, with 51% women.

In 2024, Ying Tang wrote 69 Medicare Part D claims for 28 patients. 81% of them were for generic drugs. They cover 18 drugs, with $55,719 in total drug cost. In 2021, CMS named 247 claims across 15 drugs.

Ying Tang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Ying Tang, published from 2015 to 2018. The most frequent topics are Antibodies, Monoclonal, Humanized, Complementarity Determining Regions and Immunoglobulin G. Ying Tang has published most often in MAbs.

CMS Open Payments shows 1 general payment to Ying Tang from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $44.